State of Michigan Retirement System Sells 100 Shares of Humana Inc. (NYSE:HUM)

State of Michigan Retirement System lessened its holdings in Humana Inc. (NYSE:HUMFree Report) by 0.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 32,725 shares of the insurance provider’s stock after selling 100 shares during the period. State of Michigan Retirement System’s holdings in Humana were worth $8,303,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in HUM. Creative Financial Designs Inc. ADV increased its holdings in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 61 shares during the last quarter. FPC Investment Advisory Inc. acquired a new position in Humana in the 4th quarter valued at about $27,000. Centricity Wealth Management LLC bought a new position in Humana in the 4th quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new stake in Humana during the third quarter worth approximately $31,000. Finally, Atwood & Palmer Inc. boosted its holdings in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after acquiring an additional 60 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.32% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent research reports. StockNews.com lowered Humana from a “buy” rating to a “hold” rating in a research note on Wednesday. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $247.00 to $308.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reissued an “outperform” rating and set a $283.00 target price on shares of Humana in a report on Wednesday, February 12th. JPMorgan Chase & Co. decreased their price target on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Finally, Morgan Stanley dropped their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 12th. Twenty analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $285.68.

Read Our Latest Report on HUM

Humana Price Performance

Shares of HUM stock opened at $262.10 on Thursday. The business has a fifty day simple moving average of $271.53 and a 200 day simple moving average of $284.92. The company has a market cap of $31.62 billion, a P/E ratio of 26.34, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUMGet Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.35%. Humana’s payout ratio is presently 35.58%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.